Stefanie Johns

Stefanie Johns, PhD, is an experienced regulatory affairs professional with a strong background in the biotechnology and pharmaceutical sectors. Currently serving as the Director of Regulatory Affairs at Cellphire Therapeutics, Inc. and Kymanox, Stefanie also holds positions as Chief Scientific Officer and Scientific Advisory Board Member at Hoth Therapeutics, Inc. In prior roles, Stefanie contributed to Enable Injections, Inc. as both Director and Associate Director of Regulatory Affairs, and at Camargo Pharmaceutical Services as Manager of Regulatory Strategy and Scientific and Regulatory Specialist. This extensive experience underscores a deep expertise in regulatory strategy and scientific leadership within the industry.